Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 170

1.

Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.

Gai Z, Gui T, Hiller C, Kullak-Ublick GA.

J Biol Chem. 2016 Jan 29;291(5):2397-411. doi: 10.1074/jbc.M115.694323. Epub 2015 Dec 11.

PMID:
26655953
2.

[5-0xoproline (pyroglutamic acid) acidosis and acetaminophen- a differential diagnosis in high anion gap metabolic acidosis].

Weiler S, Bellmann R, Kullak-Ublick GA.

Ther Umsch. 2015 Dec;72(11-12):737-41. doi: 10.1024/0040-5930/a000745. German.

PMID:
26654818
3.

Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.

Sigaroudi A, Kullak-Ublick GA, Weiler S.

Eur J Clin Pharmacol. 2015 Dec 3. [Epub ahead of print] No abstract available.

PMID:
26631062
4.

Too frequent low-dose methotrexate prescriptions: multicentre quality control and quality assurance with pre- and post-analysis.

Karlen S, Oertle M, Weiler S, Schneemann M, Eschmann E, Kullak-Ublick GA, Blaser J.

Swiss Med Wkly. 2015 Nov 24;145:w14218. doi: 10.4414/smw.2015.14218. eCollection 2015.

5.

[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].

Dahmke H, Kupferschmidt H, Kullak-Ublick GA, Weiler S.

Praxis (Bern 1994). 2015 Oct 14;104(21):1129-34. doi: 10.1024/1661-8157/a002160. German.

PMID:
26463904
6.

Therapeutic Drug Monitoring of Daptomycin: A Retrospective Monocentric Analysis.

Reiber C, Senn O, Müller D, Kullak-Ublick GA, Corti N.

Ther Drug Monit. 2015 Oct;37(5):634-40. doi: 10.1097/FTD.0000000000000196.

PMID:
26384039
7.

Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.

Visentin M, Stieger B, Merz M, Kullak-Ublick GA.

J Pharmacol Exp Ther. 2015 Nov;355(2):145-51. doi: 10.1124/jpet.115.227546. Epub 2015 Sep 1.

PMID:
26330539
8.

The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment.

de Vallière C, Vidal S, Clay I, Jurisic G, Tcymbarevich I, Lang S, Ludwig MG, Okoniewski M, Eloranta JJ, Kullak-Ublick GA, Wagner CA, Rogler G, Seuwen K.

Am J Physiol Gastrointest Liver Physiol. 2015 Sep 15;309(6):G475-90. doi: 10.1152/ajpgi.00408.2014. Epub 2015 Jul 23.

PMID:
26206859
9.

Drug-induced liver injury: the dawn of biomarkers?

Weiler S, Merz M, Kullak-Ublick GA.

F1000Prime Rep. 2015 Mar 3;7:34. doi: 10.12703/P7-34. eCollection 2015. Review.

10.

G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation.

de Vallière C, Wang Y, Eloranta JJ, Vidal S, Clay I, Spalinger MR, Tcymbarevich I, Terhalle A, Ludwig MG, Suply T, Fried M, Kullak-Ublick GA, Frey-Wagner I, Scharl M, Seuwen K, Wagner CA, Rogler G.

Inflamm Bowel Dis. 2015 Jun;21(6):1269-81. doi: 10.1097/MIB.0000000000000375.

11.

Liver safety assessment in special populations (hepatitis B, C, and oncology trials).

Kullak-Ublick GA, Merz M, Griffel L, Kaplowitz N, Watkins PB.

Drug Saf. 2014 Nov;37 Suppl 1:S57-62. doi: 10.1007/s40264-014-0186-3. Review.

12.

Methodology to assess clinical liver safety data.

Merz M, Lee KR, Kullak-Ublick GA, Brueckner A, Watkins PB.

Drug Saf. 2014 Nov;37 Suppl 1:S33-45. doi: 10.1007/s40264-014-0184-5. Review.

13.

Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitivity in obese mice.

Chin SH, Item F, Wueest S, Zhou Z, Wiedemann MS, Gai Z, Schoenle EJ, Kullak-Ublick GA, Al-Hasani H, Konrad D.

Diabetes. 2015 Apr;64(4):1131-41. doi: 10.2337/db14-0779. Epub 2014 Oct 16.

14.

Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature.

Basler M, Jetter A, Fink D, Seifert B, Kullak-Ublick GA, Trojan A.

Breast Care (Basel). 2014 Jul;9(3):182-7. doi: 10.1159/000363426.

15.

Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney.

Gai Z, Hiller C, Chin SH, Hofstetter L, Stieger B, Konrad D, Kullak-Ublick GA.

Biochim Biophys Acta. 2014 Sep;1842(9):1870-8. doi: 10.1016/j.bbadis.2014.07.001. Epub 2014 Jul 10.

16.

The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes.

Schaffner CA, Mwinyi J, Gai Z, Thasler WE, Eloranta JJ, Kullak-Ublick GA.

Liver Int. 2015 Apr;35(4):1152-61. doi: 10.1111/liv.12558. Epub 2014 Apr 29.

17.

Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy.

Mwinyi J, Vokinger K, Jetter A, Breitenstein U, Hiller C, Kullak-Ublick GA, Trojan A.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1181-8. doi: 10.1007/s00280-014-2453-5. Epub 2014 Mar 29.

PMID:
24682508
18.

Rivaroxaban postmarketing risk of liver injury.

Russmann S, Niedrig DF, Budmiger M, Schmidt C, Stieger B, Hürlimann S, Kullak-Ublick GA.

J Hepatol. 2014 Aug;61(2):293-300. doi: 10.1016/j.jhep.2014.03.026. Epub 2014 Mar 28.

PMID:
24681117
19.

[A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].

Piezzi V, Kullak-Ublick GA, Glisenti P.

Internist (Berl). 2014 Feb;55(2):199-205. doi: 10.1007/s00108-013-3419-0. German.

PMID:
24419536
20.

Atypical antipsychotic poisoning in young children: a multicentre analysis of poisons centres data.

Meli M, Rauber-Lüthy C, Hoffmann-Walbeck P, Reinecke HJ, Prasa D, Stedtler U, Färber E, Genser D, Kupferschmidt H, Kullak-Ublick GA, Ceschi A.

Eur J Pediatr. 2014 Jun;173(6):743-50. doi: 10.1007/s00431-013-2241-y. Epub 2013 Dec 27.

PMID:
24370666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk